Mirae Asset Global ETFs Holdings
ADMA icon

Mirae Asset Global ETFs Holdings’s ADMA Biologics ADMA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.15M Buy
127,172
+2,435
+2% +$38.4K ﹤0.01% 1455
2025
Q4 		$2.28M Sell
124,737
-1,182
-0.9% -$19.9K ﹤0.01% 1096
2025
Q3 		$1.85M Sell
125,919
-14,147
-10% -$243K ﹤0.01% 1178
2025
Q2 		$2.55M Sell
140,066
-7,099
-5% -$145K ﹤0.01% 994
2025
Q1 		$2.92M Sell
147,165
-1,473
-1% -$25.5K 0.01% 945
2024
Q4 		$2.56M Buy
148,638
+10,047
+7% +$189K 0.01% 1001
2024
Q3 		$2.76M Buy
138,591
+20,672
+18% +$321K 0.01% 963
2024
Q2 		$1.32M Buy
+117,919
New +$989K ﹤0.01% 1306

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return